Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay. | Front Pediatr | 2023 | 38078329 | PubTator, text mining | PubMed |
| Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies. | Hematology Am Soc Hematol Educ Program | 2023 | 38066845 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals key genes and environmental toxin exposures underlying treatment response in ulcerative colitis based on in-silico analysis and Mendelian randomization. | Aging (Albany NY) | 2023 | 38059894 | PubTator, text mining | PubMed |
| Editorial: Tooth enamel research: Enamel 10 and beyond. | Front Physiol | 2023 | 38028793 | PubTator, text mining | PubMed |
| The potential role of miRNA in regulating macrophage polarization. | Heliyon | 2023 | 38027572 | PubTator, text mining | PubMed |
| Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. | Clin Med Insights Endocrinol Diabetes | 2023 | 38023736 | PubTator, text mining | PubMed |
| scAAV2-Mediated Expression of Thioredoxin 2 and C3 Transferase Prevents Retinal Ganglion Cell Death and Lowers Intraocular Pressure in a Mouse Model of Glaucoma. | Int J Mol Sci | 2023 | 38003443 | PubTator, text mining | PubMed |
| Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders. | Biomolecules | 2023 | 38002295 | PubTator, text mining | PubMed |
| Exploring Circulating Long Non-Coding RNAs in Mild Cognitive Impairment Patients' Blood. | Biomedicines | 2023 | 38001964 | PubTator, text mining | PubMed |
| Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma. | Noncoding RNA | 2023 | 37987364 | PubTator, text mining | PubMed |
| Selectivity matters: selective ROCK2 inhibitor ameliorates established liver fibrosis via targeting inflammation, fibrosis, and metabolism. | Commun Biol | 2023 | 37980369 | PubTator, text mining | PubMed |
| Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation. | PLoS One | 2023 | 37972144 | PubTator, text mining | PubMed |
| Lysophosphatidic acid exerts protective effects on HEI-OC1 cells against cytotoxicity of cisplatin by decreasing apoptosis, excessive autophagy, and accumulation of ROS. | Cell Death Discov | 2023 | 37968255 | PubTator, text mining | PubMed |
| The Current Advancement in Psoriasis. | Cureus | 2023 | 37965393 | PubTator, text mining | PubMed |
| Modulating asthma-COPD overlap responses with IL-17 inhibition. | Front Immunol | 2023 | 37965351 | PubTator, text mining | PubMed |
| Alizarin, an Agonist of AHR Receptor, Enhances CYP1A1 Enzyme Activity and Induces Transcriptional Changes in Hepatoma Cells. | Molecules | 2023 | 37959792 | PubTator, text mining | PubMed |
| ROCK Inhibitors in Corneal Diseases and Glaucoma-A Comprehensive Review of These Emerging Drugs. | J Clin Med | 2023 | 37959203 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. | Int J Mol Sci | 2023 | 37958660 | PubTator, text mining | PubMed |
| NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. | Circ Res | 2023 | 37955115 | PubTator, text mining | PubMed |
| The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer. | Front Oncol | 2023 | 37936608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=16